RecruitingNot Applicable

Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention

United States60 participantsStarted 2025-02-10

Plain-language summary

The overarching goal is to develop and demonstrate proof-of-concept of ReSPECT (Reproductive and Sexual Health Patient Education and Communication Tool), a multi-modal communication intervention to improve adolescent and young adult (AYA)- clinician sexual and reproductive health (SRH) communication in the outpatient oncology clinic setting.

Who can participate

Age range15 Years – 25 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Be aged 15-25 years old at time of enrollment.
✓. Have a cancer diagnosis and currently be on cancer-directed therapy with at least one of the following:
✓. Chemotherapy: any anticancer drug to treat the cancer diagnosis, including immunotherapy.
✓. Radiotherapy: any radiotherapy to treat the cancer diagnosis.
✓. Surgery: any surgery to remove cancer including partial of total resections. Biopsies are not considered surgery.
✓. Be greater than or equal to 2 months from diagnosis/initiation of therapy, whichever occurred later.
✓. Be able to speak and read English
✓. Have permission to participate from a member of the patient's primary oncology team.

Exclusion criteria

✕. Not currently on cancer-directed therapy.
✕. Unable to speak and read English.
✕. Insufficient cognitive functioning to complete study measures (as determined by a member of the patient's primary oncology team)

What they're measuring

Feasibility of implementing the ReSPECT intervention.

Timeframe: 2 months

Acceptability of the ReSPECT intervention.

Timeframe: 2 months

Usability of the ReSPECT intervention.

Timeframe: 2 months

Perceived utility of the ReSPECT intervention.

Timeframe: 2 months

Trial details

NCT IDNCT06982066

SponsorConnecticut Children's Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2029-03-15

Contact for this trial

Natasha Frederick, MD, MPH

860-545-9618 nfrederick@connecticutchildrens.org

View on ClinicalTrials.gov More Pediatric Cancer trials

Plain-language summary

Who can participate

Age range15 Years – 25 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Be aged 15-25 years old at time of enrollment.
✓. Have a cancer diagnosis and currently be on cancer-directed therapy with at least one of the following:
✓. Chemotherapy: any anticancer drug to treat the cancer diagnosis, including immunotherapy.
✓. Radiotherapy: any radiotherapy to treat the cancer diagnosis.
✓. Surgery: any surgery to remove cancer including partial of total resections. Biopsies are not considered surgery.
✓. Be greater than or equal to 2 months from diagnosis/initiation of therapy, whichever occurred later.
✓. Be able to speak and read English
✓. Have permission to participate from a member of the patient's primary oncology team.

Exclusion criteria

✕. Not currently on cancer-directed therapy.
✕. Unable to speak and read English.
✕. Insufficient cognitive functioning to complete study measures (as determined by a member of the patient's primary oncology team)